Skip to content

Retinal Function in Diabetic Patients Without Retinopathy

Assessment of Retinal Functional Abnormalities in Diabetic Patients Without Retinopathy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00839150
Acronym
NEURODIAB
Enrollment
56
Registered
2009-02-09
Start date
2005-05-31
Completion date
2007-05-31
Last updated
2011-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Keywords

Diabetic retinopathy, Color vision, Contrast sensitivity, Electroretinogram, Flicker-induced vasodilatation, Dynamic Vessel Analyzer

Brief summary

The primary purpose was to assess, in diabetic patients without diabetic retinopathy and control subjects, color vision, contrast sensitivity, electroretinography, and flicker-induced vasodilatation using the Dynamic Vessel Analyzer, in order to specify the earliest impaired retinal cells in diabetes, and gain more insight into diabetic retinopathy pathogenesis.

Detailed description

Type 1 and type 2 diabetic patients with no diabetic retinopathy and no hypertension were compared with sex and age-matched control subjects. Color vision was tested with the desaturated LANTHONY 15-Hue test. Contrast sensitivity was assessed with the Pelli-Robson contrast sensitivity test. Pattern-electroretinogram, Ganzfeld full-field electroretinogram and multifocal electroretinogram were recorded according to the International Society for Clinical Electrophysiology of Vision (ISCEV). Flicker-induced vasodilatation in retinal arteries and veins was assessed using the Dynamic Vessel Analyzer.

Interventions

None listed

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* For diabetic patients : * age between 20 and 55 * type 1 or type 2 diabetes mellitus * diabetes duration of more than 5 years * no diabetic retinopathy on fundus examination or fundus photographs * For control subjects : * sex and age matching with the diabetic patients * no diabetes, no familial or personal history of elevated blood sugar

Exclusion criteria

\*For both diabetic patients and control subjects : * presence of cataract or history of cataract surgery * intraocular pressure of more than 21 mmHg * abnormal score on the Ishihara test * other ocular disease * ametropia more than 3 diopters, anisometropia more than 1 diopter, astigmatism more than 1 diopter * systemic hypertension (defined as systolic blood pressure \> 140 mmHg, diastolic blood pressure \> 90 mmHg) * treatment with vasoactive drugs * tobacco consumption of more than 20 cigarettes a day

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026